Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2007; Volume 191, Supplement 660
Belgian Society for Fundamental and Clinical Physiology and Pharmacology, Autumn Meeting 2006
11/18/2006-11/18/2006
”Université Libre de Bruxelles”, Brussels, Belgium


ELECTROPHYSIOLOGICAL EVIDENCE FOR AN ANTAGONISTIC MODULATORY ROLE OF ADENOSINE A2A RECEPTOR ON DOPAMINE D2 RECEPTOR REGULATION OF DOWN- AND UP-STATE TRANSITIONS IN THE STRIATUM
Abstract number: O-05

Karima1 A., Gall1 D., Schiffmann1 S.N.

1Laboratoire de Neurophysiologie, Universit Libre de Bruxelles, Brussels, Belgium.

The nucleus accumbens is a brain region involved in motivation, attention, reward and drug addiction. The output of this area is determined by the bursting activity in the medium-sized spiny GABAergic neurons (MSN), which is central to basal ganglia function and dysfunction. These bursts are driven by multiple corticostriatal inputs that depolarize MSN from their resting hyperpolarized membrane potential around -80 mV, which is recognized as the down-state, to a more depolarized level near -55 mV, called the up-state. These transitions between down- and up-state require channels regulated by several striatal transmitters acting through G protein coupled receptors. These transmitters are therefore in position to tightly control the excitability and firing patterns of the MSN. Among these neurons, enkephalin and dopamine D2 receptor-expressing neurons are highly enriched in adenosine A2A receptor. This co-expression of the D2 and A2A receptors supports strong interactions between them but their physiological significance at the cellular level remains partially unclear.

In the present study, perforated patch clamp recordings on acute rat brain slices were performed to characterize the role of D2-A2A receptors interactions in the neuromodulation of transitions between down- and up -state by using the D2 receptor agonist norapomorphine (NPA) and the A2A receptor agonist CGS 21680.

To cite this abstract, please use the following information:
Acta Physiologica 2007; Volume 191, Supplement 660 :O-05

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE